The International Commission on Radiological Protection dose limits for radiation protection have been based on linearly extrapolating the high-dose risk coefficients obtained from the Japanese A bomb survivor data to low doses. The validity of these extrapolations has been questioned from time to time. To overcome this, epidemiological studies have been undertaken across the world on populations chronically exposed to low-radiation levels. In the past decade, the results of these studies have yielded widely differing, and sometimes, contradictory, conclusions. While recent residential radon studies have shown statistically significant radon risks at low doses, high-level natural radiation (HLNR) studies in China and India have not shown any low-dose risks. Similar is the case of a congenital malformation study conducted among the HLNR area populations in Kerala, India. It is thus necessary to make efforts at overcoming the uncertainties in epidemiological studies. In the context of HLNR studies, assigning radon and thoron doses has largely been an area of considerable uncertainty. Conventionally, dosimetry is carried out using radon concentration measurements, and doses have been assigned using assumed equilibrium factors for the progeny species. Gas-based dose assignment is somewhat inadequate due to variations in equilibrium factors and possibly due to significant thoron. In this context, passive, deposition-based progeny dosimetry appears to be a promising alternative method to assess inhalation doses directly. It has been deployed in various parts of India, including HBRAs and countries in Europe. This presentation discusses the method, the results obtained and their relevance to dose assignment in Indian epidemiological studies.
Thoron gas and its progeny behave quite differently in room environments, owing to the difference in their half-lives; therefore, it is important to measure simultaneously gas and progeny concentrations to estimate the time-integrated equilibrium factor. Furthermore, thoron concentration strongly depends on the distance from the source, i.e. generally walls in indoor environments. In the present work, therefore, the measurements of both thoron and radon gas and their progeny concentrations were consistently carried out close to the walls, in 43 dwellings located in the Sokobanja municipality, Serbia. Three different types of instruments have been used in the present survey to measure the time-integrated thoron and radon gas and their progeny concentrations simultaneously. The equilibrium factor for thoron measured 'close to the wall', [Formula: see text], ranged from 0.001 to 0.077 with a geometric mean (GM) [geometric standard deviation (GSD)] of 0.006 (2.2), whereas the equilibrium factor for radon, FRn, ranged from 0.06 to 0.95 with a GM (GSD) of 0.23 (2.0).
Inhalation doses due to radon and thoron are predominantly due to the inhalation of progeny of Radon and Thoron. The progeny/decay-products of radon and thoron are particulates unlike their parent gas and exhibit different physical properties like attachment to the aerosols and deposition on different surfaces. All these properties in turn depend on the environmental conditions such as air velocity, aerosol concentration, attachment rate, etc. The role of air velocity on deposition on surfaces decides the progeny particles left in the air for inhalation. Therefore, in the present work, we have studied the effect of air velocity on the inhalation dose due to radon and thoron progeny at the centre of a 0.5-m3 calibration chamber as well as on all surfaces. Hence, the studies were carried out at different air velocities, and inhalation doses were measured using deposition-based direct radon and thoron progeny sensors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.